Sputnik Light demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered. In February 2021, Kazakhstan approved the two-dose Sputnik V vaccine.
The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September. The parties intend to produce over 300 million doses of the vaccine in India per year.
Aikening™ is a new fusion inhibitor. It is the first and only long-acting injectable (as IV infusion QW) available as a dual therapy for treatment-experienced patients with HIV-1 replication.